Spect
Palo Alto
About Spect
Spect is a data science company and the leading provider of end-to-end eye disease screening solutions. Our mission is to prevent blindness with the early detection of eye disease and to build a platform for healthcare data analytics. Since the eye is *the Check Engine Light of the Body*™, it serves as a key predictor of eye diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration, as well as whole-body diseases, such as stroke, Parkinson's, and more. Our AI-enabled telemedicine platform trains medical assistants and renders a diagnostic report in minutes. We fill a critical healthcare gap for patients and clinics while delivering best-in-class service and financial outcomes. For more information, visit: www.getspect.com or email us at [email protected].
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: Seed
- Last round: Seed (Nov 2021)
- Website: getspect.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/spect-52379 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.